Lista de obras -

A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients

artículo científico publicado en 2012

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it

artículo científico publicado en 2014

Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer

artículo científico publicado en 2019

BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer

artículo científico publicado en 2013

Cancer and the microbiome: potential applications as new tumor biomarker

artículo científico publicado en 2014

Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy

artículo científico

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer.

artículo científico publicado en 2018

HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions ⬇️

artículo científico publicado el 8 de agosto de 2013

HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma

artículo científico publicado en 2015

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

artículo científico publicado en 2015

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

artículo científico publicado en 2014

MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? ⬇️

artículo científico publicado el 12 de noviembre de 2012

Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors

artículo científico publicado en 2011

Multisciplinary management of patients with liver metastasis from colorectal cancer

artículo científico publicado en 2016

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

artículo científico publicado en 2015

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

artículo científico publicado en 2016

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

artículo científico publicado en 2015

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.

artículo científico publicado en 2015

The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? ⬇️

artículo científico publicado el 4 de enero de 2013

The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?

artículo científico publicado en 2014

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis

artículo científico

Lista de obras de

A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it

Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer

BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancer

Cancer and the microbiome: potential applications as new tumor biomarker

Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer.

HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions ⬇️

HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma

Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: a retrospective analysis

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? ⬇️

Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors

Multisciplinary management of patients with liver metastasis from colorectal cancer

New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis.

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients.

The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? ⬇️

The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target?

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis